Clinical Trial Update: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 trial assesses safety and immunogenicity of two intradermal rabies vaccine regimens administered with or without human rabies immunoglobulin in particip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Human Rabies Immunoglobulin (human rabies immunoglobulin)
• Rabies vaccine (intradermal) (rabies vaccine)

Snippet

Sponsor: Novartis | Conditions: Rabies Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-04-07